Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes. (Q30308044)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56930239)
(P304) 3012-3024
(P407) (Q1860)
(P433) 10
(P478) 7
(P577) Monday, October 1, 2001
(P921) (Q5452194)
(P1433) (Q332253)
(P1476) "Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes" (language: en)
(P2093) Slingluff CL Jr
Yamshchikov G
Neese P
Galavotti H
Eastham S
Kittlesen D
Deacon D
Hibbitts S
Grosh WW
Petroni G
Cohen R
Wiernasz C
Patterson JW
Conway BP
Ross WG
other details
description scientific article

External Links